Back to Trials
NCT07459582Recruiting

Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease

Connecticut Children's Medical Center

Start Date

8/1/2026

Completion Date

12/1/2027

Summary

The goal of this study is to determine if the Lactate Plus meter is accurate compared to lab lactate levels, and to determine if the Accu chek guide glucometer is accurate compared to lab serum glucose levels in patients with Glycogen Storage Disease Types Ia, Ib and XI. To determine this, patient's will have a one-time planned admission to Connecticut Children's for approximately 8 hours and receive hourly blood draws as well as finger-sticks.

Eligibility Criteria

Age Range: No minimum to 60 years

Inclusion Criteria: 1. Patients with diagnosed/confirmed (by liver biopsy or genetic testing) Glycogen Storage Disease Type Ia/Ib (ICD 10 code: E74.01) or XI (74.09). 2. For pediatric participants: Ability of child's parent/legal guardian to understand and the willingness to sign a written informed consent document 3. For adolescents: assent to participate 4. For adults: Ability to understand and the willingness to sign a written informed consent Exclusion Criteria: 1. Patients with Glycogen storage disease unspecified 2. Patients not meeting inclusion criteria 3. Patients unable to provide consent 4. Patients who decline to be in the study

Interventions

OTHER

Lactate Meter

DEVICE

Accu Chek

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Glycogen Storage Disease Type IAGlycogen Storage Disease Type IGlycogen Storage Disease Type IBGlycogen Storage Disease Xi

Locations

Connecticut Children's

Hartford, Connecticut 06106

United States